PLAT and Stroke: For this reason, in addition to the improvement of recanalization techniques, it is imperative to find novel neuroprotective molecules or strategies useful in a long-lasting/permanent artery occlusion scenario (9) like that faced by most stroke patients worldwide because they are not eligible or do not have the opportunity to receive tissue plasminogen activator (tPA) or to benefit from thrombectomy (10, 11).